INNV
Premium GrowerInnovAge Holding Corp. · Healthcare · United States · $1.3B cap · $5.6M/day traded
$9.40 -1.1% · close 12 Nov · scored 13 Nov
Premium Grower: Strong business with the market behind it, priced at a premium.
As of 13 Nov 2026, the MoatMap Score for InnovAge Holding Corp. (INNV) is 77/100, ranked against 25,000+ stocks in 38 markets (Quality 65, Value 33, Momentum 76, each scored against its sector).
Does the score work? Each tenth of the ranking, tracked monthly. See the record →
ABOUT INNOVAGE HOLDING CORP.
Read
InnovAge Holding Corp. is a leading provider of comprehensive healthcare services to frail seniors through the Program of All-Inclusive Care for the Elderly (PACE), delivering coordinated medical, social, and long-term care. Its competitive moat is its specialized integrated care model, which effectively manages complex senior health needs within a community setting, improving outcomes and reducing institutionalization. InnovAge is a prominent national player in the PACE market, addressing the unique challenges of an aging population.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 698.6M | 688.1M | 763.9M | 853.7M | 6.9% | 1.0B | 926.3M | 1.0B | 5.4% |
| EPS | -0.36 | -0.05 | -0.30 | -0.16 | -0.22 | — | 0.06 | — | — | — |
| Shares | — | 135.5M | 135.6M | 136.1M | 135.4M | -0.1% | 136.5M | — | — | — |
| Debt | — | 84.8M | 108.8M | 113.0M | 101.1M | 6.0% | 83.9M | — | — | — |
| Equity | — | 332.4M | 296.3M | 269.3M | 235.0M | -10.9% | — | — | — | — |
| Op CF | — | 27.3M | 20.2M | -36.9M | 32.9M | 6.4% | 89.5M | — | — | — |
| Inv CF | — | -40.2M | -69.5M | -26.4M | -5.5M | — | — | — | — | — |
| Fin CF | — | -6.3M | -7.9M | -7.0M | -19.1M | — | — | — | — | — |
No clear trend: not near its 52-week low, and not in a steady uptrend.
Swung more than 82% of stocks we rank over the past year (volatility 69% a year).
How this is worked out
The Price check reads only the chart, the price side of the Momentum score in words; it is not the MoatMap Score.
- Still falling: It set a new 52-week low in the last two weeks, after a deep fall.
- Finding a floor: It fell hard, but has set no new low for more than two weeks.
- Turning up: It has climbed off its low and is back above a rising 50-day average.
- In an uptrend: It is near its 52-week high and above its 200-day average.
- No clear trend (this stock): None of the above: no recent deep fall and no steady climb.
- No read yet: Not enough price history yet: it needs a year of trading.
In past US falls, waiting for Turning up cut the chance of another 20% drop from 42% to 33%. Returns were no better, and 33% of turns failed.
The exact rules
Still falling is a new 52-week low in the last two weeks, at least 25% below the high, with the low set after the high. Finding a floor is the same fall with no new low in the last two weeks. Turning up is 20 or more trading days without a new low, at least 10% off it, and back above a rising 50-day average. In an uptrend is above the 200-day average, with the 50-day average above the 200-day, and within 15% of the high. No clear trend is everything else. No read yet is under 252 trading days of history, or missing data. A new state shows once it has held for three trading days.
In 2,112 US drawdowns since 2001, buying while the price was still falling was followed by a further 20% drop 42% of the time. Waiting for a turn (the Turning up rule above) cut that to 33%, at about 7% higher prices and with no better returns. Part of that cut is simply not buying: 13% of falls never turned, and waiting kept those out. Among turns that were bought, 38% still fell another 20%, and 33% of turns were followed by a new low within six months. The benefit was largest in crashes such as 2008 and 2020.
What it measures: how much the price moved day to day over the past year, scaled to a yearly figure (annualised volatility) and ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of INNV are excluded.
| Ticker | Company | Mkt Cap | Score |
|---|---|---|---|
| INNV | InnovAge Holding Corp.(you) | $1.3B | 77 |
| USPH | U.S. Physical Therapy, Inc. | $1.3B | 65 |
| ASTH | Astrana Health, Inc. | $1.9B | 65 |
| GMRS | GMR Solutions Inc. | $580M | 73 |
| SGRY | Surgery Partners, Inc. | $2.1B | 64 |
| HCSG | Healthcare Services Group, Inc. | $1.7B | 95 |
| NUTX | Nutex Health Inc. | $1.4B | 99 |
| NHC | National HealthCare Corporation | $3.7B | 73 |
| GRDN | Guardian Pharmacy Services, Inc. | $2.5B | 88 |
| AMN | AMN Healthcare Services, Inc. | $1.9B | 94 |
Peer medians: ROE -31.0% · P/E 25.7x · Gross margin 62.7%
Company Deep Dive
A 10,000-word report: the business and its segments, what management promised on earnings calls and whether it delivered, the competition, and how things could turn out.